dihydroergotamine has been researched along with cp 93129 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boccalini, P; Moskowitz, MA; Nozaki, K | 1 |
Castanon, N; Chauveau, J; Chaveau, J; Hen, R; Macor, JE; Moskowitz, MA; Scearce, K; Waeber, C; Yu, XJ | 1 |
2 other study(ies) available for dihydroergotamine and cp 93129
Article | Year |
---|---|
CP-93,129, sumatriptan, dihydroergotamine block c-fos expression within rat trigeminal nucleus caudalis caused by chemical stimulation of the meninges.
Topics: Animals; Animals, Newborn; Capsaicin; Carrageenan; Dihydroergotamine; Formaldehyde; Gene Expression Regulation, Neoplastic; Guinea Pigs; Immunohistochemistry; In Vitro Techniques; Indoles; Meninges; Nasal Mucosa; Proto-Oncogene Proteins c-fos; Pyridines; Pyrroles; Rats; Sulfonamides; Sumatriptan | 1992 |
5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl -tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine1B receptors.
Topics: Animals; Capillary Permeability; Dihydroergotamine; Dipeptides; Mice; Mice, Knockout; Pyridines; Pyrroles; Pyrrolidines; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists; Sumatriptan; Trigeminal Ganglion | 1996 |